MITA News

  • MITA News

    Bucking a negative assessment from its own appointed review panel, the U.S. Centers for Medicare and Medicaid Services (CMS) on Monday approved CT lung cancer screening for Medicare recipients, saying the evidence is sufficient to justify screening high-risk individuals until the age of 74 years.

  • MITA News

    As technology advances, the imaging industry likewise develops safeguards to protect patients and promote the highest quality care. We do this in part by creating and implementing standards. The National Electrical Manufacturers Association (NEMA) and Medical Imaging & Technology Alliance (MITA) have taken the lead to create rigorous standards and encourage their adoption across the industry.

  • MITA News

    According to The National Breast Cancer Foundation, 98 percent of breast cancer patients survive – if detection occurs early. Since the late 1960s, traditional mammography has been used widely for breast cancer detection. The future of breast cancer care, however, lies in even earlier detection and individually tailored diagnosis and treatment, and imaging manufacturers are developing technologies that make these possible.

  • MITA News
    10.09.14

    The Dose Debate

    During the last 5 years, a spotlight has been cast on the issue of radiation dose management, fueled by public concern in the aftermath of two incidents of excessive radiation administered in California in 2009.

  • MITA News

    The Medical Imaging & Technology Alliance (MITA) today said a new analysis published in the Annals of Internal Medicine confirms the value of low-dose computed tomography (LDCT) lung imaging for high-risk Medicare-eligible patients. “These findings provide even more direct evidence of the benefits of low-dose CT imaging for detecting lung cancer in Medicare beneficiaries at high risk for this deadly disease,” said Gail Rodriguez, executive director of MITA.

  • MITA News

    The Medical Imaging & Technology Alliance (MITA) recently traveled to Brazil to discuss regulatory and commercial priorities for the medical imaging and radiation therapy industries there, the alliance announced. MITA successfully completed a week of meetings with Brazilian regulators, health officials, and industry stakeholders. “The market for medical imaging and radiation therapy technology in Brazil has grown rapidly over the past decade” said Gail Rodriguez, executive director of MITA.

  • MITA News

    The medical imaging technology industry supports an estimated 12,124 jobs and generates about $3.1 billion in total economic activity in the state of Washington, according to a recent economic impact analysis commissioned by the Medical Imaging and Technology Alliance (MITA). “We knew [Washington] was a hub of the technology industry related to ultrasound and the innovations that happened over the past several years — it’s been really exciting,” Brian Connell, director of government relations at MITA, told DOTmed News. “We knew that anecdotally, but we really wanted to look harder and more deeply at exactly what that meant for the state of Washington economically.”

  • MITA News

    The medical imaging technology industry supports an estimated 12,124 jobs and generates about $3.1 billion in total economic activity in the state of Washington, according to a recent economic impact analysis commissioned by the Medical Imaging and Technology Alliance (MITA). “We knew [Washington] was a hub of the technology industry related to ultrasound and the innovations that happened over the past several years — it’s been really exciting,” Brian Connell, director of government relations at MITA, told DOTmed News. “We knew that anecdotally, but we really wanted to look harder and more deeply at exactly what that meant for the state of Washington economically.”

  • MITA News

    Washington’s medical imaging technology industry is responsible for more than 12,000 jobs in Washington state and has already pumped about $3.1 billion into the state’s economy this year, according to a new study.

  • MITA News

    For centuries, the inner workings of the human brain have eluded the world’s scientists and physicians. Now, advances in neuroimaging techniques can address previously unanswered questions about how the brain functions and how distressing and costly diseases such as Alzheimer’s and Parkinson’s develop and progress. Innovations in diagnostic imaging, such as computed tomography (CT), positron emission tomography (PET), molecular imaging and the hybrid modality of PET and magnetic resonance (MR), can identify the causes of a stroke, rule out Alzheimer’s and correctly diagnose Parkinson’s. They offer the potential to detect disease and the ability to explore the brain’s frontier. Increasing access to these technologies will improve health and save lives while lowering healthcare costs.

  • PRESS CONTACT

    Albin Sikora
    (202) 585-2727
    asikora@powelltate.com


  • Imaging Forward

    In just 20 years, medical imaging has dramatically improved health outcomes and lowered costs. Imagine what the future holds. Learn More


  • The State of Medical Imaging

    New MITA Infographic highlights the current threats to medical imaging, as well as patient-centered policy proposals. Learn More

  • Elekta

    Why I Joined MITA – Elekta

    Hear from Rajinder Singh Dhada, Vice President of Strategic Partnerships, Elekta, on why his organization joined MITA.

    Learn More